kaal:position:2026-07-31-1079

Zebrafish Wnt/β-Catenin Signaling Reporters Facilitate Understanding of In Vivo Dynamic Regulation and Discovery of Therapeutic Agents should be assessed against Kaal's source-bound claim that Contingent capital qualifies as a dynamic regulatory mechanism because capital injection is available only if and when needed and because the conversion of contingent capital securities into near worthless equity signals impending regulatory issues to regulators, which creates feedback effects. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

• contingent capital securities are outstanding and their conversion is observable by regulators
• External evidence level: metadata only.
• Mapping review tier: moderate-confidence claim review.
• The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Zebrafish Wnt/β-Catenin Signaling Reporters Facilitate Understanding of In Vivo Dynamic Regulation and Discovery of Therapeutic Agents

kaal:claim:2957645-025
Kaal, Dynamic Regulation via Contingent Capital (2017). SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2957645
Source PDF sha256: 250b10782a5ea5dece9235a7f711aee408feaf36f2e78e310d589b5ee6304be2

Evidence: metadata only
Review tier: moderate-confidence claim review
Mapping confidence: 0.3612
Mapping ambiguous: true

contingent-capitaldynamic-regulationinstitutional-design

Affirmed in historical-backfill:2026-07-31:phase-0005 on 2026-07-31. Review record.

Canonical markdown sha256: 847511d97b4de9928b927b61f2e005157fb19658d02757b6044e79c27f1e41af
curl -s https://wulfkaal.github.io/positions/2026-07-31-1079.md | sha256sum